Question 1

What is ClearPoint Neuro, Inc. Common Stock's WACC?

Accepted Answer

ClearPoint Neuro, Inc. Common Stock (CLPT) has a Weighted Average Cost of Capital (WACC) of 10.86%. This is calculated using a Cost of Equity of 11.22% (via CAPM with a beta of 1.84) and a pre-tax Cost of Debt of 7.29%, with an equity weight of 90.89% in the capital structure.

Question 2

Is ClearPoint Neuro, Inc. Common Stock's WACC high or low?

Accepted Answer

ClearPoint Neuro, Inc. Common Stock's WACC of 10.86% falls within the typical 8-12% range for mid-cap growth companies. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is ClearPoint Neuro, Inc. Common Stock's WACC calculated?

Accepted Answer

ClearPoint Neuro, Inc. Common Stock's WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 11.22% is derived from the CAPM model using a beta of 1.84. The pre-tax Cost of Debt (Rd) is 7.29%. The capital structure is 90.89% equity and 9.11% debt.

ClearPoint Neuro, Inc. Common Stock (CLPT) — WACC 分析

WACC 构成

解读

ClearPoint Neuro, Inc. Common Stock（CLPT）WACC：10.86%

WACC计算器

ClearPoint Neuro, Inc. Common Stock（CLPT） WACC 解读

CLPT 公司分析

CLPT DCF 估值

继续做同行对比